To get the most out of BPC-157, focus on proper timing, suggested use, and storage
Athira Pharma (formerly M3 Biotechnology), the WSU spinout founded to commercialize Dihexa-derivative compounds, paid approximately $4 million in a False Claims Act settlement in January 2025 after a whistleblower exposed concealment of the research misconduct from federal grant agencies, and approximately $10 million in a separate class-action settlement to investors
Dose, Duration, and Individual Risk Factors in Glutathione Depletion Acetaminophen-induced glutathione depletion is dose- and duration-dependent
Molecular Biology Reports, 48(7), 3562-3575
Who IGF-1 LR3 Is For and Who Should Avoid It IGF-1 LR3 has no FDA-approved human indication